Retrospective analysis of clinical trial safety data for pembrolizumab reveals the effect of co-occurring infections on immune-related adverse events

• Tigran Makunts ,

  Roles Conceptualization, Formal analysis, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing

  * E-mail: tmakunts@health.ucsd.edu

  Affiliation Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California, United States of America

  https://orcid.org/0000-0001-5536-1266

  ⨯
• Keith Burkhart,

  Roles Conceptualization, Methodology, Supervision, Writing – review & editing

  Affiliation Office of Clinical Pharmacology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, United States of America

  ⨯
• Ruben Abagyan,

  Roles Conceptualization, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California, United States of America

  https://orcid.org/0000-0001-9309-2976

  ⨯
• Peter Lee

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Supervision, Visualization, Writing – original draft, Writing – review & editing

  Affiliation Office of Clinical Pharmacology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, United States of America

  ⨯